Tobacco 20
- Bioresearch Monitoring Program Inspections: Processes and Procedures for Site Evaluations (DRAFT)
- Remote Regulatory Assessments for FDA-Regulated Products and Establishments (DRAFT)
- Translation of Non-English Good Laboratory Practice (GLP) Study Reports (DRAFT)
- Use of Whole Slide Imaging in GLP Nonclinical Toxicology Studies
- Histopathology Peer Review in Nonclinical Toxicology Studies
- Certificates of Confidentiality for Non-Federally Funded Research: Protection of Human Subject Privacy in FDA-Regulated Studies
- Product Recalls, Removals, and Corrections: Procedures and Best Practices
- Release of Laboratory Test Results to Responsible Parties Without Freedom of Information Act Requests
- Public Warning and Notification of Recalls Under Part 7
- Evaluating Appearance Issues and Granting Participation Authorizations for Advisory Committee Members (DRAFT)
- Considering Whether FDA-Regulated Products Involve Nanotechnology
- Same-Sex Marriage Recognition in Regulatory Definitions of Spouse and Family
- Public Disclosure of Advisory Committee Members' Financial Interests and Waivers
- Public Participation in Open Public Hearing Sessions of Advisory Committee Meetings
- Voting Procedures for Advisory Committee Meetings
- Preparation and Submission of Advisory Committee Briefing Materials for Public Release
- Electronic Distribution of Product Information and Safety Communications
- Electronic Records and Electronic Signatures - Scope and Application
- Direct Final Rulemaking Procedures and Implementation Process
- Reinspection of Firms During Pending Legal Actions